In mouse models of atherosclerosis, absence of FKN or its receptor CX3CR1 protects from atherosclerotic lesion formation [7], [8], [9] and humans with a polymorphism for CX3CR1 exhibit a decreased risk for developing coronary artery disease [10], [11], [12]. This evidence concerns the gene CX3CL1 and coronary artery disorder.